NME2 and colorectal carcinoma: NME2 expression is associated with a bad prognosis in lung cancer [159], HCC, BCa, colorectal carcinoma, neuroblastoma, prostate cancer, gastric cancer, and chronic myeloid leukemia [160] has been reported to inhibit cell migration and invasion.